#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16596	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2105	781.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1364	1364	C	940	C	878	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16596	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2105	781.1	0	HET	.	.	.	C326T	.	326	326	C	506	506	C	853	C,T	599,194	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29654	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3587	823.9	0	.	n	.	0	T695C	SNP	695	695	T	1112	1112	C	911	C	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29654	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3587	823.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1754	1754	A	1012	A,G	941,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29654	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3587	823.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2388	2388	C	924	C	857	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29654	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3587	823.9	1	SNP	n	A2045G	1	A2045G	SNP	2045	2045	A	2462	2462	G	929	G	880	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29654	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3587	823.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3014	3014	C	943	C,T,A	888,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29654	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3587	823.9	0	HET	.	.	.	A412G	.	412	412	A	829	829	A	875	A,G	598,212	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2252	folP	852	852	100.0	folP.l15.c30.ctg.1	1613	139.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1077	1079	AGC	211;209;208	A;G;C	201;199;197	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5828	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3308	175.3	1	SNP	p	S91F	0	.	.	271	273	TCC	597	599	TCC	198;198;202	T;C;C	176;180;183	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5828	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3308	175.3	1	SNP	p	D95G	0	.	.	283	285	GAC	609	611	GAC	205;206;207	G;A;C	183;182;185	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5828	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3308	175.3	1	SNP	p	D95N	0	.	.	283	285	GAC	609	611	GAC	205;206;207	G;A;C	183;182;185	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1806	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1261	142.6	1	SNP	p	G45D	1	.	.	133	135	GAC	436	438	GAC	220;222;223	G;A;C	208;212;214	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	980	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1000	97.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5692	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	191.7	1	SNP	p	D86N	0	.	.	256	258	GAC	672	674	GAC	216;214;214	G;A;C	205;196;203	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5692	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	191.7	1	SNP	p	S87R	0	.	.	259	261	AGT	675	677	AGT	212;211;210	A;G;T	200;200;196	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5692	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	191.7	1	SNP	p	S87I	0	.	.	259	261	AGT	675	677	AGT	212;211;210	A;G;T	200;200;196	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5692	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	191.7	1	SNP	p	S87W	0	.	.	259	261	AGT	675	677	AGT	212;211;210	A;G;T	200;200;196	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5692	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2953	191.7	1	SNP	p	S88P	0	.	.	262	264	TCC	678	680	TCC	210;213;210	T;C;C	196;198;198	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4754	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2603	181.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1483	1485	GGC	200;197;194	G;G;C	186;183;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1213	1215	GCA	240;240;238	G;C;A,C	225;223;223,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1216	1218	ATC	240;239;239	A;T;C,G	226;227;225,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1228	1230	GTG	240;240;239	G,T;T,C;G,C	224,1;223,1;223,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1228	1230	GTG	240;240;239	G,T;T,C;G,C	224,1;223,1;223,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1732	1734	ACC	227;227;227	A;C;C	207;206;207	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1786	1788	GCG	248;246;249	G;C;G	212;201;208	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1786	1788	GCG	248;246;249	G;C;G	212;201;208	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1909	1911	GGC	186;186;182	G;G;C	171;163;165	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1918	1920	GGC	179;176;175	G;G;C	164;163;159	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4406	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2401	182.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1936	1938	CCG	159;159;159	C,G;C,G;G	115,4;116,3;116	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6376	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	2932	216.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2580	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1664	153.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	503	503	C	192	C	175	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	G46D	NONSYN	136	138	GGC	392	394	GAC	229;230;231	G;A;C	210;210;213	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	398	400	GGA	231;233;236	G,C;G;A	213,1;214;218	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	T87A	NONSYN	259	261	ACT	515	517	GCT	221;220;222	G,A;C;T	205,1;212;208	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	521	523	AGC	231;231;230	A;G;C	215;217;215	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	613	614	CG	216;213	C;G	203;196	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	616	618	CAG	211;209;208	C;A;G	197;196;193	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	620	622	AAA	202;199;201	A;A;A	187;187;190	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	N134S	NONSYN	400	402	AAT	656	658	AGT	217;214;217	A;G;T	206;204;206	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	E137K	NONSYN	409	411	GAA	665	667	AAA	214;211;212	A;A;A	203;202;202	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	683	685	GAA	218;222;220	G;A;A	205;205;205	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	707	709	GCA	233;234;237	G;C;A	214;215;213	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	815	817	CAA	233;231;231	CAAAA,CAAA;A;A	212,1;217;215	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	N189S	NONSYN	565	567	AAC	821	823	AGC	233;231;230	A;G,A;C	216;215,1;215	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	M209I	NONSYN	625	627	ATG	881	883	ATC	228;230;230	A;T;C	212;213;213	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	0	.	p	.	0	E210fs	FSHIFT	628	628	G	884	884	G	231	G	214	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	1	SNP	p	G120K	1	.	.	358	360	AAG	613	615	CGG	216;213;213	C;G;G	203;196;198	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	1	SNP	p	A121D	1	.	.	361	363	GAC	616	619	CGC	211;208;206	C;G;C	197;193;191	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2924	porB1b	1041	1041	96.76	porB1b.l6.c4.ctg.1	1545	188.0	1	SNP	p	D121N	0	.	.	361	363	GAC	616	619	CGC	211;208;206	C;G;C	197;193;191	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11874	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4919	240.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1997	1999	AAT	250;244;244	A;A;T	230;227;223	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1176	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1072	109.3	1	SNP	p	V57M	1	.	.	169	171	ATG	483	485	ATG	231;231;232	A;T;G	216;216;214	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
